Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage

Clinical trial NCT06504576 · RECRUITING

Trial details

NCT number: NCT06504576
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ICH - Intracerebral Hemorrhage

Start date: 2025-06-16
Primary completion: 2027-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.